Effect of Application and Intensity of Bevacizumab-based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-analysis-Reference-Cited by-同舟云学术

Effect of Application and Intensity of Bevacizumab-based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-analysis

Published:2016-06 Issue:2 Volume:15 Page:e29-e39
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Stein Alexander,Schwenke Carsten,Folprecht Gunnar,Arnold Dirk

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference22 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Colorectal cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

3. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

4. CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).

5. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial;Heinemann;Lancet Oncol,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023);Clinical Surgical Oncology;2023-06

2. Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review;Current Oncology Reports;2023-02-13

3. MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF metastatic colorectal cancer;ESMO Open;2022-10

4. IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy;Frontiers in Oncology;2022-09-26

5. Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer;Cancers;2021-07-13